# Inmune Bio, Inc.: Form 8-K, filed Aug 7, 2025

- Company: [Inmune Bio, Inc.](/companies/inmb.md) (CIK 1711754)
- Form: 8-K
- Filed: 2025-08-07
- Accepted by EDGAR: Aug 7, 2025, 16:17 ET
- Period: 2025-08-04
- Accession: 0001213900-25-073089
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1711754/000121390025073089/ea0251921-8k_inmune.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1711754/000121390025073089/

## Items reported

- Item 2.02: Results of operations
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1711754/000121390025073089/ea0251921-8k_inmune.htm

Filed Aug 7, 2025.
Source: SEC EDGAR, the filing index for accession 0001213900-25-073089. Last ingested by Listed: Nov 5, 2026, 16:25 ET. No prices; not investment advice.